In addition, the activation of MEKK3-KLF2/4 pathway contributes to CCM (cerebral cavernous malformations) disease (32), which is characterized by abnormal blood vessel formation in the brain due the mutations in any of the three CCM genes (CCM1–3) (33, 34). The gene discussed is KLF2; the disease is cerebral cavernous malformation.